ÂÜÀòÂÒÂ×

Michael is the chair of the board of directors, and was named Interim Chief Executive Officer in June 2021. He is also the chair of the board of Pulmatrix, Inc. and a board member at Genocea Biosciences, Nocion Therapeutics, Camp4 Therapeutics and Sea Pharmaceuticals. Previously, Michael served as entrepreneur-in-residence at Polaris Partners, senior vice president and chief operating officer of Ironwood Pharmaceuticals Inc., and held a variety of senior business positions at Genzyme Corporation, including vice president of Corporate Finance and vice president of Business Development. Prior to joining Genzyme Corporation, he led Procept, Inc.’s financial team. Michael has a B.S. from Cornell University and an M.B.A. from the Amos Tuck School of Business Administration at Dartmouth College.